What is Figur8?
FIGUR8 is dedicated to transforming musculoskeletal (MSK) health through innovative software and sensor technology, leveraging Artificial Intelligence for precise assessments and personalized treatment plans. Their FDA-registered bioMotion Assessment Platform (bMAP) delivers lab-grade biomechanics data, enhancing recovery monitoring and improving patient outcomes across various healthcare settings. The company targets providers, payers, and patients, aiming to streamline claims management and optimize risk evaluation in the MSK health sector. FIGUR8 is committed to supporting clinicians with training and resources to effectively implement their advanced technology in patient care.
How much funding has Figur8 raised?
Figur8 has raised a total of $25M across 1 funding round:
Series A
$25M
Series A (2023): $25M with participation from DigiTx Partners, First Spark Ventures, and Phoenix Venture Partners
Key Investors in Figur8
DigiTx Partners
DigiTx Partners is a venture capital firm that focuses on investing in early-stage companies within the digital health sector, aiming to address complex challenges in healthcare by supporting innovative founders and leaders who leverage technology and data. Their investment strategy emphasizes personalized medicine, data analytics, and digital therapeutics to enhance patient outcomes.
First Spark Ventures
First Spark Ventures is a Deep Tech venture capital fund that invests in breakthrough technologies aimed at enhancing health, safety, and productivity, primarily targeting companies in Pre-seed, Seed, and Series A funding rounds. Their portfolio includes innovative companies like Xona Space Systems and Inworld AI, reflecting their commitment to shaping the future through technology.
Phoenix Venture Partners
Phoenix Venture Partners is a venture capital firm that specializes in transforming innovative technologies into market-ready products, focusing on advanced materials, novel devices, and innovative manufacturing processes. They partner with visionary entrepreneurs, providing hands-on assistance in business development, IP strategy, and access to a global network.
What's next for Figur8?
With its recent major strategic investment, FIGUR8 is poised to accelerate the scaling of its AI-driven MSK health solutions. This significant capital infusion, part of its $25M in total funding, will likely fuel further research and development, expand market reach to healthcare providers and payers, and enhance the capabilities of its bioMotion Assessment Platform (bMAP). The company's focus on improving patient outcomes and streamlining claims management positions it for substantial growth within the digital health and personalized medicine sectors.
See full Figur8 company page
